Breast cancer and bone metastases: a call for appropriate treatment

被引：0
|
作者：
Diana Lüftner
Daniela Niepel
机构：
[1] Charité—Universitätsmedizin Berlin,
[2] Amgen (Europe) GmbH,undefined
来源：
Supportive Care in Cancer | 2016年 / 24卷
关键词：
Bone metastases; Bone-targeted agents; Breast cancer; SREs; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：4075 / 4077
页数：2
相关论文
共 50 条
  • [41] Targeting VEGF and its receptors in the treatment of breast cancer bone metastases
    Bachelier, Richard
    Gonin, Vincent
    Goehrig, Delphine
    Deux, Blandine
    Clezardin, Philippe
    CANCER TREATMENT REVIEWS, 2008, 34 : S77 - S77
  • [42] Bone morphogenetic protein 7 in the development and treatment of bone Metastases from breast cancer
    Buijs, Jeroen T.
    Henriquez, Nico V.
    Van Overveld, Petra G. M.
    Van der Horst, Geertje
    Que, Ivo
    Schwaninger, Ruth
    Rentsch, Cyrill
    Ten Dijke, Peter
    Cleton-Jansen, Anne-Marie
    Driouch, Keltourna
    Lidereau, Rosette
    Bachelier, Richard
    Vukicevic, Slobodan
    Clezardin, Philippe
    Papapoulos, Socrates E.
    Cecchini, Marco G.
    Loewik, Clemens W. G. M.
    Van der Pluijm, Gabri
    CANCER RESEARCH, 2007, 67 (18) : 8742 - 8751
  • [43] Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer
    Buijs, J.
    Henriquez, N.
    van Overveld, P.
    van der Horsy, G.
    Que, I.
    Schwaninger, R.
    Rentsch, C.
    ten Dijke, P.
    Cleton, A.
    Lidereau, R.
    Bachelier, R.
    Vukicevics, S.
    Clezardin, P.
    Papapoulos, S.
    Cecchini, M.
    Loewik, C.
    van der Pluijm, G.
    BONE, 2007, 40 (06) : S145 - S145
  • [44] STATUS OF BONE SCANNING FOR BONE METASTASES IN BREAST CANCER
    RUBIN, P
    CICCIO, S
    CANCER, 1969, 24 (06) : 1338 - &
  • [45] Expressiveness of Bone Markers in Breast Cancer with Bone Metastases
    Zulauf, Nicole
    Brueggmann, Doerthe
    Groneberg, David
    Oremek, Gerhard Maximilian
    ONCOLOGY, 2019, 97 (04) : 236 - 244
  • [46] Can bone markers guide more effective treatment of bone metastases from breast cancer?
    Mark Clemons
    David E.C. Cole
    Mary C. Gainford
    Breast Cancer Research and Treatment, 2006, 97 : 81 - 90
  • [47] Can bone markers guide more effective treatment of bone metastases from breast cancer?
    Clemons, M
    Cole, DEC
    Gainford, MC
    BREAST CANCER RESEARCH AND TREATMENT, 2006, 97 (01) : 81 - 90
  • [48] Application of Bone Turnover Markers PICP and β-CTx in the Diagnosis and Treatment of Breast Cancer with Bone Metastases
    Song, Binbin
    Li, Xia
    Zhou, Qiang
    Yang, Xinmei
    Jiang, Yiming
    Wang, Aifen
    CLINICAL LABORATORY, 2018, 64 (1-2) : 11 - 16
  • [49] ASSESSMENT OF RESPONSE OF BONE METASTASES TO SYSTEMIC TREATMENT IN PATIENTS WITH BREAST-CANCER
    COOMBES, RC
    DADY, P
    PARSONS, C
    MCCREADY, VR
    FORD, HT
    GAZET, JC
    POWLES, TJ
    CANCER, 1983, 52 (04) : 610 - 614
  • [50] Treatment of Bone Metastases of Breast Cancer With 177Lu-DOTA-IBA
    Deng, Jia
    Yang, Jian
    Cheng, Zixuan
    Chen, Yue
    CLINICAL NUCLEAR MEDICINE, 2024, 49 (07) : 659 - 661
12345